Oedema peripheral and Urinary retention

Summary:

Urinary retention is found among people with Oedema peripheral, especially for people who are female, 60+ old.

The study analyzes which people have Urinary retention with Oedema peripheral. It is created by eHealthMe based on reports of 71 people who have Oedema peripheral from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Oedema peripheral?

Oedema peripheral (superficial swelling) is found to be associated with 2,772 drugs and 3,465 conditions by eHealthMe. Check the latest studies of Oedema peripheral.

What is Urinary retention?

Urinary retention (the inability to completely or partially empty the bladder) is found to be associated with 1,570 drugs and 1,737 conditions by eHealthMe. Check the latest studies of Urinary retention.



On Jul, 14, 2026

71 people who have Oedema Peripheral and Urinary Retention are studied.

Would you have Urinary retention when you have Oedema peripheral?

Gender of people who have Oedema Peripheral and experienced Urinary Retention *:

  • female: 61.9 %
  • male: 38.1 %

Age of people who have Oedema Peripheral and experienced Urinary Retention *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 6.45 %
  • 60+: 93.55 %

Common co-existing conditions for these people *:

  1. Pain: 26 people, 36.62%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 19 people, 26.76%
  3. Constipation: 18 people, 25.35%
  4. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 16 people, 22.54%
  5. Nausea And Vomiting: 16 people, 22.54%
  6. Cardiac Failure: 15 people, 21.13%
  7. Fever: 13 people, 18.31%
  8. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 13 people, 18.31%
  9. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system): 13 people, 18.31%
  10. Nausea (feeling of having an urge to vomit): 13 people, 18.31%

Common drugs taken by these people *:

  1. Aspirin: 17 people, 23.94%
  2. Furosemide: 16 people, 22.54%
  3. Torsemide: 14 people, 19.72%
  4. Ondansetron: 14 people, 19.72%
  5. Letrozole: 14 people, 19.72%
  6. Palbociclib: 14 people, 19.72%
  7. Kisqali: 14 people, 19.72%
  8. Calcium: 14 people, 19.72%
  9. Novalgin: 13 people, 18.31%
  10. Fulvestrant: 13 people, 18.31%

Common symptoms for these people *:

  1. Weakness: 32 people, 45.07%
  2. Constipation: 26 people, 36.62%
  3. Nausea (feeling of having an urge to vomit): 21 people, 29.58%
  4. Urinary Tract Infection: 21 people, 29.58%
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 18 people, 25.35%
  6. Cardiac Failure: 18 people, 25.35%
  7. Infection: 18 people, 25.35%
  8. Nausea And Vomiting: 17 people, 23.94%
  9. Delirium (wild excitement): 17 people, 23.94%
  10. Primary Intestinal Pseudo-Obstruction (symptoms of intestinal blockage without any physical signs of a blockage): 17 people, 23.94%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Urinary retention?

- Check whether Urinary retention is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Urinary retention:

All the conditions that are associated with Urinary retention:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Urinary retention and Oedema peripheral, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: